Ion channel therapeutic monoclonal antibodies
SYnAbs has developed R&D and therapeutic monoclonal antibodies against transporters and ion channel such as glutamate EAAT transmembrane targets thanks to peptide and syngeneic cell immunization strategies
SYnAbs develops therapeutic effector monoclonal antibodies against ion channel transmembrane proteins thanks to DNA and cell immunization technologies
From Galvani' spark to the three-dimensional structure of ion channels, learn the fabulous history of unique transmembrane proteins